Leukichtan

Sodium Bituminosulfonate Light, the active ingredient in Leukichtan, is a topical dermatological agent presented as a skin‑applied preparation for external use. It is employed to manage inflammatory and bacterial skin conditions such as seborrheic dermatitis, psoriasis, acne and other related dermatoses.

GNH USA supplies Leukichtan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance across EU and global markets. Leukichtan is manufactured under strict GMP standards and undergoes rigorous testing before distribution.

Leukichtan (Sodium Bituminosulfonate Light) is applied topically for inflammatory and bacterial skin conditions. - Seborrheic dermatitis: Reduces scaling, erythema and itching associated with the condition. - Psoriasis: Helps diminish plaque formation and skin inflammation. - Acne vulgaris: Limits bacterial growth and calms inflammatory lesions. - Atopic dermatitis: Alleviates inflammation and reduces secondary infection risk.

Topical application of Sodium Bituminosulfonate Light may be associated with local adverse reactions.

Common Side Effects: - Skin irritation: Mild redness or burning at the application site. - Dryness: Transient skin dryness after use. - Pruritus: Itching sensation in the treated area. - Contact dermatitis: Allergic skin reaction in susceptible individuals.

Serious or Rare Side Effects: - Severe allergic reaction: Angioedema or anaphylaxis requiring immediate medical attention. - Skin ulceration: Necrotic lesions with prolonged or excessive use. - Systemic toxicity: Rare systemic absorption leading to hepatic or renal effects.

When using Leukichtan, consider the following precautions. - Avoid use on broken skin: Limit application to intact epidermis to reduce irritation. - Do not apply to mucous membranes: Keep away from eyes, mouth and genital area. - Limit exposure time: Follow prescriber instructions for duration of therapy. - Discontinue if severe irritation occurs: Seek medical advice promptly. - Pregnancy and lactation: Safety not established; consult a healthcare provider before use. - Store at ambient temperature: Keep in the original container, protect from moisture and direct sunlight.

Potential interactions with other topical agents should be considered.

Major Interactions (Avoid): - Concurrent use with other topical irritants: May increase skin irritation. - Application over areas treated with systemic antibiotics: No known interaction but monitor for unexpected effects.

Moderate Interactions (Monitor Closely): - Co‑application with corticosteroid creams: May alter efficacy of either product. - Use with other anti‑inflammatory topicals: Risk of additive irritation. - Combination with phototherapy: Monitor skin response for excessive sensitivity.